How to Buy Coeptis Therapeutics Holdings Stock

Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics, Inc. , a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer.

Coeptis Therapeutics Holdings stock last closed at $12.00, down 0.91% from the previous day, and has decreased 8.88% in one year. It has overperformed other stocks in the Biotechnology industry by 0.21 percentage points. Coeptis Therapeutics Holdings stock is currently +91.69% from its 52-week low of $6.26, and -43.95% from its 52-week high of $21.41.

At the moment, there are 5.34M COEP shares outstanding. The market capitalization of COEP is $64.08M. In the last 24 hours, 20,400 COEP shares were traded.

How to Buy Coeptis Therapeutics Holdings Stock

Not sure how to invest in Coeptis Therapeutics Holdings stock? Here's how.

  1. Choose where to buy Coeptis Therapeutics Holdings stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you decide where to buy Coeptis Therapeutics Holdings stock.
  2. Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Fund your investment account: Choose your payment method and add your info.
  4. Analyze Coeptis Therapeutics Holdings stock: The Coeptis Therapeutics Holdings ticker symbol is COEP. Is Coeptis Therapeutics Holdings stock a good investment? Should you buy shares of COEP? How do COEP's underlying business fundamentals look? Do top analysts think Coeptis Therapeutics Holdings is a good buy? Why has COEP's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if COEP is a good stock to buy).
  5. Make your COEP trade: Decide if you will purchase COEP shares at the current market price or use a limit order to buy COEP stock at a given price.
  6. Keep tabs on your investment in COEP: Create a watchlist to the latest updates on your new investment in Coeptis Therapeutics Holdings shares.

Step 1: Choose where to buy Coeptis Therapeutics Holdings stock

You will need a brokerage account to access the NASDAQ market and buy COEP shares.

A brokerage account allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best online stock brokerage. Here's why:

  • Invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
  • Access to world financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create your brokerage account

Now that you've selected the best brokerage, the next step is to fill out some personal details so you are able to invest in COEP stock today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create a new brokerage account.
  1. Send your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your investment account

Now that you have filled out your info on stock market app, you can securely and quickly fund your account:

Watch this video walkthrough for more details transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Coeptis Therapeutics Holdings stock

Once you have figured out the best place to buy Coeptis Therapeutics Holdings stock, it's crucial to analyze their stock before you invest, so you can wrap your head around the risk as well as the opportunity.

Coeptis Therapeutics Holdings Numbers

COEP Price
$12.00
1w %
-1.48%
1y %
-8.88%
5y %
-94.16%
P/E
-2.78x
P/B
6.18x
P/S
113.21x
PEG
N/A
Revenue
$501.00k
Earnings
-$11.28M
Fore. Rev. Growth
-100%
Fore. Earn. Growth
N/A
Market Cap
$64.08M
Next Earnings
N/A
Next Dividend
N/A

COEP Overview

WallStreetZen was created to help average investors perform more in-depth fundamental analysis.

You can view all of the due diligence checks on COEP's stock page.

Is COEP stock properly valued?

You can use many financial metrics, analyses, models, and charts to gauge COEP's fair value.

Using relative valuations measures:

  • COEP may be overvalued based on its P/B ratio of 6.18x, relative to Biotechnology industry P/B ratio of 5.16x

You can access additional valuation analysis on COEP's stock here.

Is COEP a healthy company?

Pros:

  • There are more short-term assets than short-term liabilities on the COEP balance sheet.
  • COEP has a low debt to equity ratio of 0.32.
  • There are more short-term assets than long-term liabilities on the COEP balance sheet.
  • Total COEP debt is lower than 5 years ago, relative to shareholder equity.

Cons:

  • COEP profit margin has gone down from N/A to -2,251.5% in the past year.
  • COEP has $5.33M in cash and short term investments. This is not sufficient to cover its annual cash burn of $8.35M.
  • COEP has cash burn of 8351664. It does not have enough cash and short-term investments to cover this.

You can dig deeper into what analysts are saying on the Coeptis Therapeutics Holdings stock forecast page.

COEP Trading Indicators

SMA10
12.12
SMA20
12.89
SMA50
14.04
SMA100
14.95
SMA200
12.74
MACD
-0.65
MACD Signal
-0.61
MACD Histogram
-0.04
RSI
41.51
Stochastic %K
27.53
Stochastic %D
27.63
StochRSI %K
57.94
StochRSI %D
56.53

COEP Performance Metrics

Last year, COEP revenue was $501.00k. Over the last four year, COEP's revenue has increased by 100.89% per year. This was faster than the Biotechnology industry average of 40.89%.

You can research COEP's earnings and revenue performance here.

Latest Insiders Trades at COEP

Over the last 12 months, insiders at COEP have bought more shares than they have sold.

Chris Calise, Director of COEP, was the latest COEP insider to buy. They bought $60,192.00 worth of COEP stock on Feb 11, 2026.

Learn more about who owns COEP shares here.

Can I get consistent income from COEP stock?

No, Coeptis Therapeutics Holdings doesn't provide an income stream by paying out dividends.

Get analysis from other traders

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Make your COEP trade

You have two primary options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally sufficient.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at a particular dollar amount, use a limit order.

Click the Open button and your broker will place the order.

If you require additional info about investing in stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in COEP

Now that you own some COEP shares, you'll want to keep up with your new stock purchase.

Create a watchlist to get the latest updates about your COEP stock.

COEP Feed

How to Buy Stock in Coeptis Therapeutics Holdings

To reiterate, here are the 6 steps to buy Coeptis Therapeutics Holdings stock:

  1. Choose where to buy Coeptis Therapeutics Holdings stock
  2. Create your brokerage account
  3. Fund your investment account
  4. Analyze Coeptis Therapeutics Holdings stock
  5. Make your COEP trade
  6. Keep tabs on your investment in COEP

If you need a brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep tabs on your investment in Coeptis Therapeutics Holdings, add COEP to your watchlist below.

NASDAQ: COEP
$12.00-0.11 (-0.91%)
Updated Feb 17, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: COEP
$12.00-0.11 (-0.91%)
Updated Feb 17, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Coeptis Therapeutics Holdings share?

As of Feb 17, 2026, it costs $12.00 to buy one share of Coeptis Therapeutics Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $6, you can buy 0.5 shares of COEP.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Coeptis Therapeutics Holdings stock?

One way to place an order for Coeptis Therapeutics Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.